12/10/2021 12:14:32 PM - Consolidating near its 52-week high, above its 50 DMA line ($102) and prior high ($99) defining important near-term support. The 11/26/21 mid-day report last noted - <i>&quot;The past 4 quarterly comparisons through Sep &#39;21 showed earnings increases above the +25% minimum guideline (C criteria), but with flat or waning sales revenues. Its up and down annual earnings (A criteria) is not a match with the fact-based investment system&#39;s fundamental guidelines.&quot;</i><br><hr>11/26/2021 11:40:20 AM - Gapped down today pulling back from near its 52-week high. Prior high and its 50 DMA line define important near-term support in the $99 area. The past 4 quarterly comparisons through Sep &#39;21 showed earnings increases above the +25% minimum guideline (C criteria), but with flat or waning sales revenues. Its up and down annual earnings (A criteria) is not a match with the fact-based investment system&#39;s fundamental guidelines.<br><hr>4/21/2021 12:35:15 PM - Pulling back from near its 52-week high and undercutting its 50 DMA line with today&#39;s 3rd consecutive loss. The past 2 quarterly comparisons through Mar &#39;21 showed earnings increases above the +25% minimum guideline (C criteria), but with waning sales revenues. Its up and down annual earnings (A criteria) is not a match with the fact-based investment system&#39;s fundamental guidelines.<br><hr>4/30/2018 12:15:20 PM - Perched near its 52-week high. Three of the past 4 quarterly comparisons through Mar &#39;18 showed earnings increases above the +25% minimum guideline (C criteria), but sub par sales revenues growth and its up and down annual earnings (A criteria) is not a match with the fact-based investment system&#39;s fundamental guidelines.<br><hr>